UNIVERSAL AAV IMMUNO-GENE THERAPY FOR CANCER
Dead / Abandoned — Abandoned — failure to respond (as of 14 Feb 2024)
What this means for you
This application is over — abandoned 01 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97772311
- Mark type
- Stylized text
- Filed
- 30 Jan 2023
- Abandoned
- 01 Feb 2024
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
- Class 042 — Scientific and technological services: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- Siren Biotechnology, Inc., San Francisco, CA, US
Prosecution history
- 14 Feb 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 14 Feb 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Oct 2023 — NON-FINAL ACTION E-MAILED
- 31 Oct 2023 — NON-FINAL ACTION WRITTEN
- 27 Oct 2023 — ASSIGNED TO EXAMINER
- 16 Feb 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Feb 2023 — NEW APPLICATION ENTERED